GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » YoY EPS Growth

Perseus Proteomics (TSE:4882) YoY EPS Growth : 100.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Perseus Proteomics's YoY EPS Growth for the quarter that ended in Sep. 2024 was 100.00%.

Perseus Proteomics's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was 円0.00.


Perseus Proteomics YoY EPS Growth Historical Data

The historical data trend for Perseus Proteomics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics YoY EPS Growth Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial -572.31 50.91 7.73 -22.87 -39.98

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -110.80 -29.83 -33.29 9.83 100.00

Perseus Proteomics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Perseus Proteomics's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-93.69--66.93)/ | -66.93 |
=-39.98 %

Perseus Proteomics's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(0--35.9)/ | -35.9 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Perseus Proteomics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Perseus Proteomics Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics Headlines

No Headlines